Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ FDA approves device to treat MGD ➤ Standalone MIGS device trial begins ➤ Topline results for novel dry eye candidate ➤ Orphan drug designation granted for topical LHON treatment ➤ Positive safety results in Phase 1/2a trial for investigational treatment of wet AMD ➤ Updates on two investigational RNA therapies ➤ ASCRS news and events
➤ Study: Possible therapy to avoid visual problems induced by space travel ➤ Exploratory study finds investigational eye drop for dry eye safe and tolerable ➤ New drug candidate in development to treat dry eye and ocular pain ➤ Results from year 2 of Phase 3 trial of brolucizumab for DME ➤ ASCRS news and events
➤ Small-aperture IOL receives approvable letter from the FDA ➤ Topline results from Phase 2 clinical trial for intracanalicular insert for treatment of dry eye disease ➤ First in-human study to target biomarkers in the eye that identify ALS ➤ Study provides better understanding for bilateral effect after unilateral injection of gene therapy ➤ ASCRS news and events
➤ Positive topline clinical data for investigational topical presbyopia treatment ➤ FDA grants IDE for modular IOL with fluid-filled optic ➤ First participants enrolled in Phase 3 trial for mydriasis reversal ➤ Analysis: Subgroup of dry eye patients benefit from investigational treatment ➤ NDA approved for generic drug designed to treat inflammation, pain ➤ First patient enrolled in Phase 2a study for wet AMD and DME candidate ➤ ASCRS news and events
➤ New 5-year data with MIGS device ➤ Phase 2 results with new epi-on crosslinking technology ➤ FDA grants IDE, authorizes trial of new viscodilation system ➤ Robotic surgery for glaucoma ➤ First patient dosed in Phase 3 trial of investigational drop for DME ➤ New glaucoma device approved in European market, plus Phase 2 results ➤ ASCRS news and events
➤ Enrollment begins in Phase 3 pilocarpine study for presbyopia ➤ New digital platform enhances connectivity among clinic-to-OR technologies ➤ Positive results from Phase 1 safety study of investigational compound for AMD, DME ➤ Alcon to acquire Ivantis ➤ ASCRS news and events
➤ FDA approves first prescription eye drop for presbyopia treatment ➤ Primary endpoint reached in Phase 2 trial for dry eye disease drug ➤ New type of retinal nerve cell discovered ➤ Companies enter collaboration to develop an oral DME, wet AMD treatment ➤ iCare USA acquires remote patient-monitoring tech company ➤ ASCRS news and events
➤ FDA approves suprachoroidal injection for macular edema associated with uveitis ➤ FDA approves first-of-its-kind approach to treat wet AMD ➤ Digital therapeutic for pediatric amblyopia receives FDA premarket approval ➤ Ocular insert for dry eye does not meet Phase 2 primary endpoint ➤ Study: Prozac as a possible treatment for AMD ➤ ASCRS news and events
➤ FDA approves nasal spray for dry eye ➤ Survey: 70% of adults don’t plan on receiving an eye exam this year ➤ Positive results in Phase 3 study for Acanthamoeba keratitis treatment ➤ Research on first-in-class therapy for retinal degenerative disease ➤ ASCRS news and events
➤ Phase 3 clinical trial results for once-daily netarsudil ophthalmic solution ➤ Dexamethasone ophthalmic insert approved for new indication ➤ Results from home OCT feasibility study ➤ FDA accepts application for brolucizumab for DME ➤ Companies form alliance to develop nomograms, lens constants and astigmatism calculations ➤ AAO announces next CEO ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.